Real-world clinical outcomes of meropenem/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections.

Zhang, Helen L; Cressman, Leigh; Lautenbach, Ebbing

Zhang, Helen L; Cressman, Leigh; Lautenbach, Ebbing.

Afiliação

Zhang HL; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Electronic address: helen.zhang1@pennmedicine.upenn.edu.
Cressman L; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Lautenbach E; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

J Glob Antimicrob Resist ; 27: 299-302, 2021 12.

Article em En | MEDLINE | ID: mdl-34775130

Assuntos

Antibacterianos; Carbapenêmicos; Adulto; Antibacterianos/uso terapêutico; Ácidos Borônicos; Carbapenêmicos/uso terapêutico; Humanos; Meropeném/uso terapêutico; Estudos Retrospectivos

Palavras-chave

CRE; Carbapenem-resistant Enterobacterales; Meropenem/vaborbactam; Multidrug-resistant organisms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbapenêmicos / Antibacterianos Tipo de estudo: Observational_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google